<div role="article" aria-roledescription="email" style="-webkit-text-size-adjust: 100%;-ms-text-size-adjust: 100%;padding: 20px 0px;margin: 0 auto;"><div style="height:0px;max-height:0px;border-width:0px;border: 0px;border-color:initial;border-image:initial;visibility:hidden;line-height:0px;font-size:0px;overflow:hidden;display:none;"></div><table id="$beacon$"><tbody><tr><td></td></tr></tbody></table><table id="stb-container" role="presentation" style="width:100%;" border="0" bordercolor=""><tbody><tr><td align="center"><!--[if mso]> <table role="presentation" align="center" style="width:630px;background:#ffffff;"> <tr> <td> <div class="outer"> <![endif]--><!--[if !mso]><!--><div class="outer" style="width:100%;max-width:630px;background:#ffffff;margin: 0px auto;"><!--<![endif]--><table width="100%" cellpadding="0" cellspacing="0" style="border:0;"><tbody><tr><td class="stb-text-box" style="padding:0 0;text-align:left;margin:0px;line-height:1.7;word-break:break-word;font-size:12px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif!important;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color:#747579;"><table border="0" cellpadding="0" cellspacing="0" style="width: 100%" class="stb-permalink"><tbody><tr><td style="padding:5px 15px 5px 15px;"><div><span style="font-weight: bold; font-style: italic;" class="stb-bold stb-italic">2026-02-27 </span></div></td></tr></tbody></table></td></tr></tbody></table><table width="100%" cellpadding="0" cellspacing="0" style="border:0;"><tbody><tr><td style="height:15px;" colspan="3"></td></tr><tr><td style="width:15px;"></td><td style="height:15px;background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;"><!-- <div style='background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;'></div> --></td><td style="width:15px;"></td></tr></tbody></table><table role="presentation" class="stb-one-col" style="width: 100%;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td style="text-align:center;font-size:0;box-sizing:border-box;padding:15px 15px 0 15px;"><a href="https://www.brpinsight.com/" target="_blank" style="text-decoration: underline; color: #ff5252;"><img src="https://img2.stibee.com/440332_3255129_1772076658653408005.png" alt="" style="width:100%;display:inline;vertical-align:bottom;text-align:center;max-width:100% !important;height:auto;border:0;" width="600" class="stb-center"></a></td></tr><tr><td style="word-break:break-all;text-align:left;margin:0px;;line-height:1.7;word-break:break-word;font-size:16px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif!important;;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color:#000000;padding:20px 15px 15px 15px;"><div style="text-align: center;"> <span style="font-size: 20px;"><span class="stb-bold" style="font-weight: bold;">🔎</span></span><br><span class="link-edited stb-bold" style="font-size: 16px; font-weight: bold;">"데이터로 읽는 시장의 흐름, BRPInsight가 엄선했습니다"</span></div></td></tr></tbody></table><table width="100%" cellpadding="0" cellspacing="0" style="border:0;"><tbody><tr><td style="height:15px;" colspan="3"></td></tr><tr><td style="width:15px;"></td><td style="height:15px;background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;"><!-- <div style='background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;'></div> --></td><td style="width:15px;"></td></tr></tbody></table><table role="presentation" class="stb-one-col" style="width: 100%;background:#F2E7FD;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td style="word-break:break-all;text-align:left;margin:0px;;line-height:1.7;word-break:break-word;font-size:16px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif!important;;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color:#000000;padding:15px 15px 15px 15px;"><div style="text-align: center;"><span style="font-weight: bold; font-size: 18px;" class="stb-bold">✨ Only BRPInsight </span></div></td></tr></tbody></table><table role="presentation" class="stb-one-col" style="width: 100%;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td style="word-break:break-all;text-align:left;margin:0px;;line-height:1.7;word-break:break-word;font-size:16px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif!important;;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color:#000000;padding:15px 15px 0 15px;"><div><span style="font-weight: bold; color: #722ed1; font-size: 18px;" class="stb-bold stb-fore-colored">📈 고혈압 치료의 대세 'ARB 복합제', 2025년 매출액 TOP5 제품은?</span></div><div><br></div><ul style="padding: 0; margin: 0 0 0 30px;"><li>안지오텐신 II 수용체 차단제(ARB) 복합제 시장이 국내 고혈압 치료의 대세로 자리 잡았습니다. 2025년 ARB 복합제 시장은 약 2조 7,040억 원대 규모를 형성하였고, 이 중 텔미사르탄/암로디핀 성분이 점유율 23.79%로 선두를 이끌고 있습니다.</li></ul><div><br></div><ul style="padding: 0; margin: 0 0 0 30px;"><li>2025년 ARB 복합제 시장에서 매출액 1위를 차지한 제품은 텔미사르탄/암로디핀 성분의 한국베링거인겔하임의 '트윈스타'입니다. 2025년 매출액 약 970억 원을 달성하며 1위에 오른 트윈스타는 24시간 지속되는 우수한 혈압 강하 효과를 자랑하는 오리지널 고정용량 복합제입니다.</li></ul><div><br></div><ul style="padding: 0; margin: 0 0 0 30px;"><li>2위는 로사르탄/암로디핀 성분의 한미약품 '아모잘탄'으로 2025년 매출액은 약 875억 원입니다. 아모잘탄은 한국인 대상의 풍부한 임상 데이터를 축적한 대표적인 국산 계량신약 블록버스터입니다.</li></ul><div><br></div><ul style="padding: 0; margin: 0 0 0 30px;"><li>고혈압 치료의 대세가 된 ARB 복합제 시장과 2025년 TOP5 제품이 궁금하다면 BRP인사이트에서 확인해 보세요.🔎</li></ul><div><br></div></td></tr><tr><td style="text-align:center;font-size:0;box-sizing:border-box;padding:20px 15px 0 15px;"><a href="https://www.brpinsight.com/contents-center/2509" target="_blank" style="text-decoration: underline; color: #ff5252;"><img src="https://img2.stibee.com/440332_3257498_1772159630230545066.png" alt="" style="width:590px;display:inline;vertical-align:bottom;text-align:center;max-width:100% !important;height:auto;border:0;" width="590" class="stb-center"></a></td></tr><tr><td class="stb-cta-box" width="100%" style="clear:both;;"><table border="0" cellpadding="0" cellspacing="0" style="width:100%;"><tbody><tr><td style="padding:20px 15px 15px 15px;border:0;width:100%;text-align:center;"><table class="stb-cell-wrap-cta" border="0" cellpadding="0" cellspacing="0" style="color:#F1F3F5;mso-padding-alt:0px;background:#722ED1;border-radius:500px;border:2px solid #722ED1;mso-line-height-rule:exactly;box-sizing:border-box;text-decoration:none;outline:0px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;text-align:center;display:inline-table;"><tbody><tr><td style="font-size:0;background:none;border-radius:500px;padding:19px 20px;text-align:center;" valign="top"><a href="https://www.brpinsight.com/contents-center/2509" style="font-size:16px;display:inline-block;color:#F1F3F5;text-decoration:none;outline:0px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;text-align:center;line-height:1;box-sizing:border-box;mso-line-height-rule:exactly;" target="_blank">상세 리포트 보러 가기</a></td></tr></tbody></table><table align="center" border="0" cellpadding="0" cellspacing="0" role="presentation"><tbody><tr></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><table width="100%" cellpadding="0" cellspacing="0" style="border:0;"><tbody><tr><td style="height:15px;" colspan="3"></td></tr><tr><td style="width:15px;"></td><td style="height:15px;background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;"><!-- <div style='background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;'></div> --></td><td style="width:15px;"></td></tr></tbody></table><table role="presentation" class="stb-one-col" style="width: 100%;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td style="word-break:break-all;text-align:left;margin:0px;;line-height:1.7;word-break:break-word;font-size:16px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif!important;;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color:#000000;padding:15px 15px 15px 15px;"><div style="text-align: center;"><span style="font-weight: bold; font-size: 18px;" class="stb-bold">📰 Daily News Clip </span></div></td></tr></tbody></table><table width="100%" cellpadding="0" cellspacing="0" style="border:0;"><tbody><tr><td style="height:15px;" colspan="3"></td></tr><tr><td style="width:15px;"></td><td style="height:15px;background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;"><!-- <div style='background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;'></div> --></td><td style="width:15px;"></td></tr></tbody></table><table role="presentation" class="stb-one-col" style="width: 100%;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td style="word-break:break-all;text-align:left;margin:0px;;line-height:1.7;word-break:break-word;font-size:16px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif!important;;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color:#000000;padding:15px 15px 0 15px;"><div><span style="font-weight: bold;" class="stb-bold">☑️ 포말리스트, 실적 하락세…제네릭·급여기준 제한 이중압박<span style="font-size: 16px;"><a href="https://www.hitnews.co.kr/news/articleView.html?idxno=74104" target="_blank" style="color: #ff5252; text-decoration: underline;">🔗</a></span></span></div><div><div><br></div><ul style="padding: 0; margin: 0 0 0 30px;"><li style="font-size: 16px;">한국BMS제약의 다발골수종 치료제 '포말리스트(성분 포말리도마이드)' 매출이 하락하고 있습니다. 제네릭 공세와 급여기준 제한 등의 악재를 풀어낼 수 있을지 관심을 모으고 있습니다.</li></ul><div><br></div><ul style="padding: 0; margin: 0 0 0 30px;"><li style="font-size: 16px;">고연령층 환자가 많은 다발골수종 질환 특성 상 경구제의 수요가 높음에도 포말리스트 병용요법의 급여기준이 3차 이상 치료로 제한돼 있어 매출액에는 긍정적인 영향을 미치지 못하고 있습니다.</li></ul><div><br></div><ul style="padding: 0; margin: 0 0 0 30px;"><li style="font-size: 16px;">제네릭 경쟁이 심화되면서 포말리스트 처방액은 더 감소할 것으로 예상됩니다.</li></ul><span style="font-size: 12px;"></span></div><div style="text-align: right;"><span style="font-size: 12px;">[히트뉴스ㅣ26.02.27]</span><br></div></td></tr><tr><td style="text-align:center;font-size:0;box-sizing:border-box;padding:20px 15px 0 15px;"><img src="https://img2.stibee.com/440332_3257498_1772155294005325231.jpg" alt="" style="width:590px;display:inline;vertical-align:bottom;text-align:center;max-width:100% !important;height:auto;border:0;" width="590" class="stb-center"></td></tr><tr><td class="stb-cta-box" width="100%" style="clear:both;;"><table border="0" cellpadding="0" cellspacing="0" style="width:100%;"><tbody><tr><td style="padding:20px 15px 15px 15px;border:0;width:100%;text-align:center;"><table class="stb-cell-wrap-cta" border="0" cellpadding="0" cellspacing="0" style="color:#F1F3F5;mso-padding-alt:0px;background:#722ED1;border-radius:500px;border:2px solid #F1F3F5;mso-line-height-rule:exactly;box-sizing:border-box;text-decoration:none;outline:0px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;text-align:center;display:inline-table;"><tbody><tr><td style="font-size:0;background:none;border-radius:500px;padding:19px 20px;text-align:center;" valign="top"><a href="https://www.brpinsight.com/brand/14480" style="font-size:16px;display:inline-block;color:#F1F3F5;text-decoration:none;outline:0px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;text-align:center;line-height:1;box-sizing:border-box;mso-line-height-rule:exactly;" target="_blank">제네릭·급여기준 제한 이중 악재, '포말리스트' 알아보기</a></td></tr></tbody></table><table align="center" border="0" cellpadding="0" cellspacing="0" role="presentation"><tbody><tr></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><table width="100%" cellpadding="0" cellspacing="0" style="border:0;"><tbody><tr><td style="height:15px;" colspan="3"></td></tr><tr><td style="width:15px;"></td><td style="height:15px;background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;"><!-- <div style='background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;'></div> --></td><td style="width:15px;"></td></tr></tbody></table><table role="presentation" class="stb-one-col" style="width: 100%;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td style="word-break:break-all;text-align:left;margin:0px;;line-height:1.7;word-break:break-word;font-size:16px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif!important;;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color:#000000;padding:15px 15px 0 15px;"><div>☑️ <span style="font-weight: bold;" class="stb-bold">스타펜 후발약 시장, 제형·용량·생산전략까지…경쟁 구도 '다층화'<a href="https://www.kpanews.co.kr/news/articleView.html?idxno=530047" class="stb-underline" style="font-weight: normal; font-style: normal; text-decoration: underline; color: #ff5252;" target="_blank">🔗</a> </span></div><div> </div><div><ul style="padding: 0; margin: 0 0 0 30px;"><li>피타바스타틴·페노피브레이트 복합제 시장이 최근 제형 다변화와 용량 조정 전략이 더해지며 다시 한번 경쟁 구도로 주목받고 있습니다.</li></ul><div><br></div><ul style="padding: 0; margin: 0 0 0 30px;"><li>한림제약의 이상지질혈증 치료 복합제 '스타펜캡슐'을 중심으로 형성된 이 시장은 특허 장벽이 높지 않은 구조 속에서 다수 국내사가 진입해 왔으며, 급여 등재 확대 이후 본격적인 출시가 이어지며 경쟁이 현실화됐습니다.</li></ul><div><br></div><ul style="padding: 0; margin: 0 0 0 30px;"><li>스타펜 후발 시장은 과거 품목 수 확대를 중심으로 형성된 경쟁 구도에서 한 단계 더 나아가, 제형 다변화와 용량 조정, 생산 구조, 약가 전략이 복합적으로 작용하는 구조로 진화하고 있습니다.</li></ul><div style="text-align: right;"><span style="font-size: 12px;">[약사공론ㅣ26.02.27]</span></div></div></td></tr><tr><td style="text-align:center;font-size:0;box-sizing:border-box;padding:20px 15px 0 15px;"><img src="https://img2.stibee.com/440332_3257498_1772155476133954709.jpg" alt="" style="width:auto;display:inline;vertical-align:bottom;text-align:center;max-width:100% !important;height:auto;border:0;" width="350" class="stb-center"></td></tr><tr><td class="stb-cta-box" width="100%" style="clear:both;;"><table border="0" cellpadding="0" cellspacing="0" style="width:100%;"><tbody><tr><td style="padding:20px 15px 15px 15px;border:0;width:100%;text-align:center;"><table class="stb-cell-wrap-cta" border="0" cellpadding="0" cellspacing="0" style="color:#F1F3F5;mso-padding-alt:0px;background:#722ED1;border-radius:500px;border:2px solid #722ED1;mso-line-height-rule:exactly;box-sizing:border-box;text-decoration:none;outline:0px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;text-align:center;display:inline-table;"><tbody><tr><td style="font-size:0;background:none;border-radius:500px;padding:19px 20px;text-align:center;" valign="top"><a href="https://www.brpinsight.com/brand/6809" style="font-size:16px;display:inline-block;color:#F1F3F5;text-decoration:none;outline:0px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;text-align:center;line-height:1;box-sizing:border-box;mso-line-height-rule:exactly;" target="_blank">피타바스타틴·페노피브레이트 복합제 시장의 중심, '스타펜캡슐' 알아보기</a></td></tr></tbody></table><table align="center" border="0" cellpadding="0" cellspacing="0" role="presentation"><tbody><tr></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><table width="100%" cellpadding="0" cellspacing="0" style="border:0;"><tbody><tr><td style="height:15px;" colspan="3"></td></tr><tr><td style="width:15px;"></td><td style="height:15px;background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;"><!-- <div style='background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;'></div> --></td><td style="width:15px;"></td></tr></tbody></table><table role="presentation" class="stb-one-col" style="width: 100%;background:#F2E7FD;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td style="word-break:break-all;text-align:left;margin:0px;;line-height:1.7;word-break:break-word;font-size:16px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif!important;;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color:#000000;padding:15px 15px 15px 15px;"><div><span style="font-size: 18px; font-weight: bold;" class="stb-bold">🔎 더 많은 시장 인사이트가 궁금하다면? </span></div></td></tr></tbody></table><table role="presentation" class="stb-one-col" style="width: 100%;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td class="stb-cta-box" width="100%" style="clear:both;;"><table border="0" cellpadding="0" cellspacing="0" style="width:100%;"><tbody><tr><td style="padding:15px 15px 15px 15px;border:0;width:100%;text-align:left;"><table class="stb-cell-wrap-cta" border="0" cellpadding="0" cellspacing="0" style="color:#722ED1;mso-padding-alt:0px;border-radius:500px;mso-line-height-rule:exactly;width:auto;box-sizing:border-box;text-decoration:none;outline:0px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;text-align:left;display:inline-table;"><tbody><tr><td style="font-size:0;background:none;border-radius:500px;padding:19px 20px;text-align:left;" valign="top"><a href="https://www.brpinsight.com/contents-center/2504" style="font-size:16px;display:inline-block;color:#722ED1;text-decoration:none;outline:0px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;text-align:left;line-height:1;box-sizing:border-box;mso-line-height-rule:exactly;width:auto;" target="_blank">🔆 [2025 ETC 시장] 지는 해 '스타틴', 뜨는 해 '에제티미브 복합제' </a></td></tr></tbody></table><table align="center" border="0" cellpadding="0" cellspacing="0" role="presentation"><tbody><tr></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><table width="100%" cellpadding="0" cellspacing="0" style="border:0;"><tbody><tr><td style="height:15px;" colspan="3"></td></tr><tr><td style="width:15px;"></td><td style="height:15px;background: none;padding: 0px;border-top-width:1px;border-top-style:dashed;border-top-color:#999999;margin:0 0;"><!-- <div style='background: none;padding: 0px;border-top-width:1px;border-top-style:dashed;border-top-color:#999999;margin:0 0;'></div> --></td><td style="width:15px;"></td></tr></tbody></table><table role="presentation" class="stb-one-col" style="width: 100%;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td class="stb-cta-box" width="100%" style="clear:both;;"><table border="0" cellpadding="0" cellspacing="0" style="width:100%;"><tbody><tr><td style="padding:15px 15px 15px 15px;border:0;width:100%;text-align:left;"><table class="stb-cell-wrap-cta" border="0" cellpadding="0" cellspacing="0" style="color:#722ED1;mso-padding-alt:0px;background:#ffffff;border-radius:500px;mso-line-height-rule:exactly;width:auto;box-sizing:border-box;text-decoration:none;outline:0px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;text-align:left;display:inline-table;"><tbody><tr><td style="font-size:0;background:none;border-radius:500px;padding:19px 20px;text-align:left;" valign="top"><a href="https://www.brpinsight.com/contents-center/2744" style="font-size:16px;display:inline-block;color:#722ED1;text-decoration:none;outline:0px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;text-align:left;line-height:1;box-sizing:border-box;mso-line-height-rule:exactly;width:auto;" target="_blank">🆚 [2025 OTC 시장] 판콜 vs 판피린, OTC 시장의 영원한 숙적</a></td></tr></tbody></table><table align="center" border="0" cellpadding="0" cellspacing="0" role="presentation"><tbody><tr></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><table width="100%" cellpadding="0" cellspacing="0" style="border:0;"><tbody><tr><td style="height:15px;" colspan="3"></td></tr><tr><td style="width:15px;"></td><td style="height:15px;background: none;padding: 0px;border-top-width:1px;border-top-style:dashed;border-top-color:#999999;margin:0 0;"><!-- <div style='background: none;padding: 0px;border-top-width:1px;border-top-style:dashed;border-top-color:#999999;margin:0 0;'></div> --></td><td style="width:15px;"></td></tr></tbody></table><table role="presentation" class="stb-one-col" style="width: 100%;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td class="stb-cta-box" width="100%" style="clear:both;;"><table border="0" cellpadding="0" cellspacing="0" style="width:100%;"><tbody><tr><td style="padding:15px 15px 15px 15px;border:0;width:100%;text-align:left;"><table class="stb-cell-wrap-cta" border="0" cellpadding="0" cellspacing="0" style="color:#722ED1;mso-padding-alt:0px;background:#ffffff;border-radius:500px;mso-line-height-rule:exactly;width:auto;box-sizing:border-box;text-decoration:none;outline:0px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;text-align:left;display:inline-table;"><tbody><tr><td style="font-size:0;background:none;border-radius:500px;padding:19px 20px;text-align:left;" valign="top"><a href="https://www.brpinsight.com/contents-center/2910" style="font-size:16px;display:inline-block;color:#722ED1;text-decoration:none;outline:0px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;text-align:left;line-height:1;box-sizing:border-box;mso-line-height-rule:exactly;width:auto;" target="_blank">🦶 [Market Rank] 주블리아가 평정한 '국소용 항진균제' 시장</a></td></tr></tbody></table><table align="center" border="0" cellpadding="0" cellspacing="0" role="presentation"><tbody><tr></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><table width="100%" cellpadding="0" cellspacing="0" style="border:0;"><tbody><tr><td style="height:15px;" colspan="3"></td></tr><tr><td style="width:15px;"></td><td style="height:15px;background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;"><!-- <div style='background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;'></div> --></td><td style="width:15px;"></td></tr></tbody></table><table role="presentation" class="stb-one-col" style="width: 100%;background:#ffffff;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td style="text-align:justify;font-size:0;box-sizing:border-box;padding:25px 15px 25px 15px;"><a href="https://www.brpinsight.com/" target="_blank" style="text-decoration: underline; color: #ff5252;"><img src="https://img2.stibee.com/440332_3255129_1772085216974426135.png" alt="" style="width:100%;display:inline;vertical-align:bottom;text-align:justify;max-width:100% !important;height:auto;border:0;" width="600" class="stb-justify"></a></td></tr></tbody></table><table width="100%" cellpadding="0" cellspacing="0" style="border:0;"><tbody><tr><td class="stb-text-box stb-permalink stb-footer" style="text-align:center;margin:0px;;line-height:1.7;word-break:break-word;font-size:12px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif!important;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color:#747579;border:0;"><table border="0" cellpadding="0" cellspacing="0" style="width: 100%"><tbody><tr><td style="padding:15px 15px 15px 15px;text-align:center;"><div><span class="stb-fore-colored" style="color: #959595;">BRPInsight</span></div><div>brpnews@brpinsight.com<br><span class="stb-fore-colored" style="color: #959595;">(주)BRP커넥트ㅣ서울시 동작구 동작대로 77(사당동)ㅣ</span><br><span class="stb-fore-colored" style="color: #959595;"><a href="$%unsubscribe%$" class="stb-fore-colored stb-underline" style="text-decoration: underline; color: #959595;" target="_blank"><span style="font-weight: normal; font-style: normal;">수신거부</span></a> <a href="$%unsubscribe%$" class="stb-fore-colored stb-underline" style="text-decoration: underline; color: #959595;" target="_blank"><span style="font-weight: normal; font-style: normal;">Unsubscribe</span></a></span></div></td></tr></tbody></table></td></tr></tbody></table></div><!--[if mso]> </td> </tr> </table> <![endif]--></td></tr></tbody></table><div style="padding: 10pt 0cm 10pt 0cm;"><p class="MsoNormal" align="center" style="text-align: center;"><span lang="EN-US"></span></p></div></div>